Spine Surgery and Related Research
Online ISSN : 2432-261X
ISSN-L : 2432-261X
Characteristics and Postoperative Outcomes in Spinal Metastases of Cancer of Unknown Primary: A Multicenter Prospective Cohort Study
Ryosuke Hirota, Tsutomu Oshigiri, Noriyuki Iesato, Makoto Emori, Atsushi Teramoto, Yuki Shiratani, Akinobu Suzuki, Koji Tamai, Takaki Shimizu, Takashi Yurube, Yutaro Kanda, Hiroyuki Tominaga, Ichiro Kawamura, Masayuki Ishihara, Masaaki Paku, Yohei Takahashi, Toru Funayama, Kousei Miura, Eiki Shirasawa, Hirokazu Inoue, Atsushi Kimura, Takuya Iimura, Hiroshi Moridaira, Hideaki Nakajima, Shuji Watanabe, Koji Akeda, Norihiko Takegami, Kazuo Nakanishi, Hirokatsu Sawada, Koji Matsumoto, Masahiro Funaba, Hidenori Suzuki, Haruki Funao, Takashi Hirai, Bungo Otsuki, Kazu Kobayakawa, Koji Uotani, Hiroaki Manabe, Shinji Tanishima, Ko Hashimoto, Chizuo Iwai, Daisuke Yamabe, Akihiko Hiyama, Shoji Seki, Yuta Goto, Masashi Miyazaki, Kazuyuki Watanabe, Toshio Nakamae, Takashi Kaito, Hiroaki Nakashima, Narihito Nagoshi, Satoshi Kato, Shiro Imagama, Kota Watanabe, Gen Inoue, Takeo Furuya
Author information
JOURNAL OPEN ACCESS Advance online publication

Article ID: 2026-0385

Details
Abstract

Introduction: Spinal metastases from cancer of unknown primary (SMCUP) pose distinct diagnostic and therapeutic challenges because the primary tumor is unidentified at presentation. This study evaluated surgical outcomes in patients with SMCUP, focusing on survival and patient-reported outcomes (PROs).

Methods: This multicenter prospective registry study analyzed data from the Japan Association of Spine Surgeons with Ambition registry, including 413 patients with spinal metastases treated at 34 institutions between 2018 and 2021. Of these, 34 patients had no identifiable primary tumor at the time of orthopedic consultation (SMCUP cohort). Sixteen patients were subsequently diagnosed after surgery (diagnosed group), whereas 18 remained without an identified primary tumor (non-diagnosed group). Survival, PROs, and tumor characteristics were evaluated preoperatively and at 1 and 6 months after surgery.

Results: Postoperative survival and PROs were comparable between the SMCUP and non-SMCUP groups. Within the SMCUP cohort, however, the non-diagnosed group demonstrated poorer 6-month survival than the diagnosed group (62.1% vs. 89.2%; p = 0.042), together with less favorable PROs. Hematologic malignancies accounted for 50% of the postoperatively identified primary tumors, highlighting the importance of systematic hematologic evaluation in patients with SMCUP.

Conclusions: Spinal surgery was associated with favorable neurological outcomes and PROs while facilitating identification of the primary tumor in a substantial proportion of patients. These findings support the dual therapeutic and diagnostic role of surgery in the management of SMCUP.

Content from these authors
© 2026 The Japanese Society for Spine Surgery and Related Research.

SSRR is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. Anyone may download, reuse, copy, reprint, or distribute articles published in the journal for not-for-profit purposes if they cite the original authors and source properly. If you remix, transform, or build upon the material, you may not distribute the modified material.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top